Form 4 for VVOS Vivos Therapeutics, Inc.
Accepted 2021-09-22 00:00:00 ET · period of report 2021-09-21 · accession 0001493152-21-023354 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-22 | 2021-09-21 | VVOS | Huntsman Ronald Kirk | CEO, Dir | P - Purchase | $4.31 | +5,000 | 15.5K | +48% | +$21.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-21 | P | A | 5,000 | $4.31 | 15,500 | D | — | — |